Mask pattern verification apparatus employing super-resolution
technique, mask pattern verification method employing super-resolution
technique, and medium with program thereof
    2.
    发明授权
    Mask pattern verification apparatus employing super-resolution technique, mask pattern verification method employing super-resolution technique, and medium with program thereof 失效
    使用超分辨率技术的掩模图案验证装置,采用超分辨率技术的掩模图案验证方法,以及其程序的介质

    公开(公告)号:US6038020A

    公开(公告)日:2000-03-14

    申请号:US158526

    申请日:1998-09-22

    申请人: Eiji Tsukuda

    发明人: Eiji Tsukuda

    摘要: A mask pattern verification apparatus includes a semiconductor circuit layout unit for generating layout data from semiconductor circuit data, a super-resolution corresponding pattern verification unit for verifying a pattern of the layout data generated by the semiconductor circuit layout unit according to a pitch with a line width and a space width, an optical simulation unit carrying out optical simulation on an error site of a pitch detected by the super-resolution corresponding pattern verification unit to output light intensity, and a contour output unit for generating and providing a contour according to the light intensity output from the optical simulation unit.

    摘要翻译: 掩模图案验证装置包括:半导体电路布局单元,用于从半导体电路数据生成布局数据;超分辨率对应图案验证单元,用于根据具有线的间距来验证由半导体电路布局单元生成的布局数据的图案 宽度和空间宽度的光学模拟单元,在由超分辨率对应模式验证单元检测到的音调的误差位置上执行光学模拟以输出光强度的光学模拟单元,以及用于生成和提供根据 从光学模拟单元输出的光强度。

    QUINAZOLINE DERIVATIVES AS KINASE INHIBITORS
    7.
    发明申请
    QUINAZOLINE DERIVATIVES AS KINASE INHIBITORS 失效
    喹诺酮衍生物作为激酶抑制剂

    公开(公告)号:US20100113468A1

    公开(公告)日:2010-05-06

    申请号:US12471280

    申请日:2009-05-22

    IPC分类号: A61K31/497

    摘要: The present invention relates to nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which have inhibitory activity on the phosphorylation of kinases, which inhibits the activity of such kinases. The invention is also related to a method of inhibiting kinases and treating disease states in a mammal by inhibiting the phosphorylation of kinases. In a particular aspect the present invention provides nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which inhibit phosphorylation of a PDGF receptor to hinder abnormal cell growth and cell wandering, and a method for preventing or treating cell-proliferative diseases such as arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis.

    摘要翻译: 本发明涉及对抑制这种激酶活性的激酶磷酸化具有抑制活性的含氮杂环化合物及其药学上可接受的盐。 本发明还涉及通过抑制激酶的磷酸化来抑制哺乳动物的激酶和治疗疾病状态的方法。 在一个特定方面,本发明提供了抑制PDGF受体的磷酸化以阻止异常细胞生长和细胞游动的含氮杂环化合物及其药学上可接受的盐,以及预防或治疗细胞增殖性疾病如动脉硬化,血管 重建,癌症和肾小球硬化症。

    Nitrogenous heterocyclic compounds
    8.
    发明申请
    Nitrogenous heterocyclic compounds 审中-公开
    含氮杂环化合物

    公开(公告)号:US20060063770A1

    公开(公告)日:2006-03-23

    申请号:US11200456

    申请日:2005-08-08

    IPC分类号: A61K31/517

    摘要: The present invention relates to nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which have inhibitory activity on the phosphorylation of kinases, which inhibits the activity of such kinases. The invention is also related to a method of inhibiting kinases and treating disease states in a mammal by inhibiting the phosphorylation of kinases. In a particular aspect the present invention provides nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof which inhibit phosphorylation of a PDGF receptor to hinder abnormal cell growth and cell wandering, and a method for preventing or treating cell-proliferative diseases such as arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis.

    摘要翻译: 本发明涉及对抑制这种激酶活性的激酶磷酸化具有抑制活性的含氮杂环化合物及其药学上可接受的盐。 本发明还涉及通过抑制激酶的磷酸化来抑制哺乳动物的激酶和治疗疾病状态的方法。 在一个特定方面,本发明提供了抑制PDGF受体的磷酸化以阻止异常细胞生长和细胞游动的含氮杂环化合物及其药学上可接受的盐,以及预防或治疗细胞增殖性疾病如动脉硬化,血管 重建,癌症和肾小球硬化症。